Women's Health Issues
Volume 22, Issue 1 , Pages e19-e26 , January 2012

Appalachian and Non-Appalachian Pediatricians’ Encouragement of the Human Papillomavirus Vaccine: Implications for Health Disparities

  • Janice L. Krieger, PhD

      Affiliations

    • School of Communication, The Ohio State University, Columbus, Ohio
    • Corresponding Author InformationCorrespondence to: Janice L. Krieger, School of Communication, The Ohio State University, 3058 Derby Hall, 154 North Oval Mall, Columbus OH 43221.
    • ,
  • Mira L. Katz, PhD

      Affiliations

    • College of Public Health, The Ohio State University, Columbus, Ohio
    • ,
  • Jennifer A. Kam, PhD

      Affiliations

    • Department of Communication at the University of Illinois at Urbana-Champaign, Illinois
    • ,
  • Anthony Roberto, PhD

      Affiliations

    • Hugh Downs School of Communication, Arizona State University, Tempe, Arizona

Received 5 February 2011 ,Revised 28 June 2011 ,Accepted 13 July 2011.

References 

  1. Allen JD, Othus M, Shelton RC, Li Y, Norman N, Tom L, et al. Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers, & Prevention. 2010;19:2187–2198
  2. Barnack JL, Reddy DM, Swain C. Predictors of parents’ willingness to vaccinate for human papillomavirus and physicians’ intentions to recommend the vaccine. Women’s Health Issues. 2010;20:28–34
  3. Chou B, Krill LS, Horton BB, Barat CE, Trimble CL. Disparities in human papillomavirus vaccine completion among vaccine initiators. Obstetrics & Gynecology. 2011;118:14–20
  4. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988;
  5. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. Journal of Adolescent Health. 2007;40:101–103
  6. Daley MF, Liddon N, Crane LA, Beaty BL, Barrow J, Babbel C, et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics. 2006;118:2280–2289
  7. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: A survey of U.S. physicians 19 months after licensure. Pediatrics. 2010;126:425–433
  8. Dillman DA. Mail and internet surveys: The tailored design method. updated 2nd ed. New York: Wiley; 2006;
  9. Dinh T, Sternberg M, Dunne EF, Markowitz L. Genital warts among 18- to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999–2004. Sexually Transmitted Diseases. 2008;35:357–360
  10. Dorell C, Yankey D, Cohn A, Markowitz L. National, state, and local area vaccination coverage among adolescents aged 13–17 years—United States, 2009. Morbidity and Mortality Weekly Report (MMWR). 2010;59:1018–1023
  11. Duval B, Gilca V, McNeil S, Dobson S, Money D, Gemmill IM, et al. Vaccination against human papillomavirus: A baseline survey of Canadian clinicians’ knowledge, attitudes, and beliefs. Vaccine. 2007;25:7841–7847
  12. Esposito S, Bosis S, Pelucchi C, Begliatti E, Rognoni A, Bellasio M, et al. Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine. 2007;25:6437–6446
  13. Feemster KA, Winters SE, Fiks AG, Kinsman S, Kahn J. Pediatricians’ intention to recommend human papillomavirus (HPV) vaccines to 11- to 12-year-old girls postlicensing. Journal of Adolescent Health. 2008;43:408–411
  14. Graham JW. Missing data analysis: Making it work in the real world. Annual Review of Psychology. 2009;60:549–576
  15. Graham JW, Cumsille PE, Elek-Fisk E. Methods of handling missing data. In:  Schinka JA,  Velicer WF editor. Research Methods in Psychology. New York: John Wiley & Sons; 2003;p. 87–114
  16. Halverson JA, Barnett E, Casper M. Geographic disparities in heart disease and stroke mortality among black and white populations in the Appalachian region. Ethnicity & Disease. 2002;12(Suppl. 3):82–91
  17. Haverson J, Ma L, Harner EJ. An analysis of disparities in health status and access to care in the Appalachian region. Washington, DC: Appalachian Regional Commission; 2004;Available from: http://www.arc.gov/index.do?nodeId=2467&print=yes
  18. Harbaugh R. Proven lessons for generating good mail survey response rates from physicians. Medical Marketing and Media. 2002;37:3–7
  19. Heritage J, Robinson JD, Elliot MN, Beckett M, Wilkes M. Reducing patients’ unmet concerns in primary care: The difference one word can make. Journal of General Internal Medicine. 2007;22:1429–1433
  20. Hopenhayn C, Christian A, Christian WJ, Schoenberg NE. Human papillomavirus vaccine: Knowledge and attitudes in two Appalachian Kentucky counties. Cancer Causes and Control. 2007;18:627–634
  21. Hopenhayn C, King JB, Christian A, Huang B, Christian WJ. Variability of cervical cancer rates across 5 Appalachian states, 1998–2003. Cancer. 2008;113(Suppl. 10):2974–2980
  22. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling. 1999;6:1–55
  23. Huang B, Wyatt S, Tucker T, Bottorff D, Lengerich E, Hall HI. Cancer death rates-Appalachia 1994–1998. Morbidity and Mortality Weekly Report (MMWR). 2002;51:527–529
  24. Jain P, Krieger JL. Moving beyond the language barrier: The communication strategies used by international medical graduates in intercultural medical encounters. Patient Education & Counseling. 2011;84:98–104
  25. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet G. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstetrics & Gynecology. 2008;111:1103–1110
  26. Katz ML, Reiter PL, Heaner S, Ruffin MT, Post DM, Paskett ED. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine. 2009;27:3945–3952
  27. Kline RB. Principles and practice of structural equation modeling. New York: Guilford Press; 2005;
  28. Krieger JL, Kam J, Katz M, Roberto AJ. Does mother know best? An actor-partner model of college-age females' HPV vaccination behavior. Human Communication Research. 2011;37:107–124
  29. Lindsey LLM. Anticipated guilt as behavioral motivation: An examination of appeals to help unknown others through bone marrow donation. Human Communication Research. 2005;31:453–481
  30. Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta D, Dunne EF. Post-licensure monitoring of the HPV vaccine in the United States. Vaccine. 2010;28:4731–4737
  31. Morrison K. Motivating women and men to take protective action against rape: Examining direct and indirect persuasive fear appeals. Health Communication. 2005;18:237–256
  32. Muthén LK, Muthén BO. Mplus user’s guide. 5th ed. Los Angeles, CA: Muthén & Muthén; 1998–2007;
  33. Parkin DM. The global health burden of infection-associated cancers in the year 2002. International Journal of Cancer. 2006;118:3030–3044
  34. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods. 2008;40:879–891
  35. Reiter PL, Brewer NT, Gottlieb SL, McRee A, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Social Science & Medicine. 2009;69:475–480
  36. Rimal RN, Real K. Perceived risk and efficacy beliefs as motivators of change: Use of the risk perception attitude (RPA) framework to understand health behaviors. Human Communication Research. 2003;29:370–399
  37. Roberto AJ, Krieger JL, Katz M, Goei R, Jain P. Predicting pediatricians’ communication with parents about the human papillomavirus (HPV) vaccine: An application of the theory of reasoned action. Health Communication. 2011;26:303–312
  38. Roberto AJ, Goodall CE. Using the extended parallel process model to explain physician’s decisions to test their patients for kidney disease. Journal of Health Communication. 2009;14:400–412
  39. Rosenthal SL, Rupp R, Zimet G, Meza HM, Loza ML, Short MB, et al. Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. Journal of Adolescent Health. 2008;43:239–245
  40. Pruitt SL, Schootman M. Geographic disparity, area poverty, and human papillomavirus vaccination. American Journal of Preventive Medicine. 2010;38:525–533
  41. Schluterman NH, Terplan M, Lydecker AD, Tracy JK. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine. 2011;29:3767–3772
  42. Tambor ES, Chase GA, Faden RR, Geller G, Hofman KJ, Holtzman NA. Improving response rates through incentive and follow-up: The effect on a survey of physicians’ knowledge of genetics. American Journal of Public Health. 1993;83:1599–1603
  43. U.S. Centers for Disease Control and Prevention . FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report (MMWR). 2010, May 28;59:630–632
  44. U.S. Food and Drug Administration. (2010, December 22). FDA: Gardasil approved to prevent anal cancer. Available: www.fda.gov. Accessed December 30, 2010.
  45. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011;127:77–84
  46. Witte K. Putting the fear back into fear appeals: The extended parallel process model. Communication Monographs. 1992;59:329–349
  47. Witte K, Berkowitz J, Cameron K, Lillie J. Preventing the spread of genital warts: Using fear appeals to promote self-protective behaviors. Health Education & Behavior. 1998;25:571–585
  48. Witte K, Cameron KA, McKeon JK, Berkowitz JM. Predicting risk behaviors: Development and validation of a diagnostic scale. Journal of Health Communication. 1996;1:317–341
  49. Witte K, Morrison K. The use of scare tactics in AIDS prevention: The case of juvenile detention and high school youth. Journal of Applied Communication Research. 1995;23:128–142
  50. Zimet GD. Improving adolescent health: Focus on HPV vaccine acceptance. Journal of Adolescent Health. 2005;37:S17–S23

 Supported by a grant from The Ohio State University Coordinating Committee for the Population and Health: Targeted Investments in Excellence Initiative (PI: Krieger), National Cancer Institute Grants K07 CA107079 (MLK), and the Behavioral Measurement Shared Resource at The Ohio State University Comprehensive Cancer Center, P30 CA016058.

PII: S1049-3867(11)00169-1

doi: 10.1016/j.whi.2011.07.005

Women's Health Issues
Volume 22, Issue 1 , Pages e19-e26 , January 2012

Article Tools

* Image Usage & Resolution